中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [28]
深圳先进技术研究院 [15]
高能物理研究所 [6]
合肥物质科学研究院 [4]
过程工程研究所 [3]
上海应用物理研究所 [3]
更多
采集方式
OAI收割 [70]
iSwitch采集 [4]
内容类型
期刊论文 [71]
会议论文 [2]
学位论文 [1]
发表日期
2024 [2]
2023 [1]
2022 [5]
2021 [4]
2020 [2]
2019 [3]
更多
学科主题
Chemistry [1]
Engineerin... [1]
Materials ... [1]
物理化学 [1]
生物科学::植物学 [1]
筛选
浏览/检索结果:
共74条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2024, 卷号: 15, 期号: 1, 页码: 20
作者:
Miao, Yunqiu
;
Li, Lijun
;
Wang, Ying
;
Wang, Jiangyue
;
Zhou, Yihan
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2024/03/13
Unraveling the complex roles of macrophages in obese adipose tissue: an overview
期刊论文
OAI收割
FRONTIERS OF MEDICINE, 2024, 页码: 32
作者:
Peng, Chang
;
Chen, Jun
;
Wu, Rui
;
Jiang, Haowen
;
Li, Jia
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2024/02/19
obesity
inflammation
adipose tissue macrophages
adipose tissue homeostasis
Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12
作者:
Lin, Ting-ting
;
Xiong, Wei
;
Chen, Gui-hua
;
He, Yang
;
Long, Li
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2024/01/26
osimertinib resistance
targeted drug delivery
liposomes
panobinostat
tumor-associated macrophage
combination therapy
Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast Cancer
期刊论文
OAI收割
ADVANCED MATERIALS, 2022, 卷号: 34, 期号: 33, 页码: 2205462
作者:
Zhao, Zitong
;
Fang, Lei
;
Xiao, Ping
;
Sun, Xiangshi
;
Zhou, Lei
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2024/03/21
chemo-immunotherapy
drug delivery
metastasis
PD-1 blockade
triple-negative breast cancer
Current approaches of nanomedicines in the market and various stage of clinical translation
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 7, 页码: 3028-3048
作者:
Shan, Xiaoting
;
Gong, Xiang
;
Li, Jie
;
Wen, Jingyuan
;
Li, Yaping
  |  
收藏
  |  
浏览/下载:135/0
  |  
提交时间:2024/03/21
Nanomedicines
Nanoparticles
Liposomes
Vaccines
Marketed products
Clinical translations
Disease-driven design
Quality by design
Remodeling "cold" tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 4, 页码: 2057-2073
作者:
He, Yang
;
Fang, Yuefei
;
Zhang, Meng
;
Zhao, Yuge
;
Tu, Bin
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/08/16
Tumor immune microenvironment
Tumor-associated macrophage
Epigenetic therapy
Immune checkpoint
Angiogenesis
Panobinostat
JQ1
Liposome
Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12, 页码: 14
作者:
Xie, Duoli
;
Wang, Zhuqian
;
Li, Jie
;
Guo, De-an
;
Lu, Aiping
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/06/15
osteosarcoma
targeted delivery
chemotherapeutic agents
ligand-based delivery systems
antibodies
用于硼中子俘获治疗的含硼药物研究现状与热点前沿: 基于文献计量的分析与思考
期刊论文
OAI收割
科学通报, 2022, 卷号: 67, 期号: 14, 页码: 1532-1545
作者:
郑丽丽
;
陈奎
;
吴鸣
;
郑春晓
;
廖青云
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2023/11/13
Combating liver cancer through GO-targeted biomaterials
期刊论文
OAI收割
BIOMEDICAL MATERIALS, 2021, 卷号: 16, 期号: 6, 页码: 14
作者:
Huang, Xing
;
Zhang, Jiaxin
;
Song, Yijie
;
Zhang, Tong
;
Wang, Bing
  |  
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2021/11/04
graphene oxide
hydroxycamptothecin
anti-cancer
drug delivery system
targeting
Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 卷号: 599
作者:
Liang, Huamin
;
Zou, Fengming
;
Liu, Qingwang
;
Wang, Beilei
;
Fu, Liyi
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2021/05/17
Liposome
Drug nanocrystal
Core-shell
Drug delivery
Tumor therapy
BCR-ABL